Loading clinical trials...
Loading clinical trials...
Sacral Neuromodulation for Patients With Multiple Sclerosis With Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction. A Multicenter Double-blind, Placebo-controlled Randomized Clinical Trial.
Conditions
Interventions
Turning ON the neuromodulator
Turning OFF the neuromodulator
Locations
1
Denmark
Odense University Hospital
Odense, Fyn, Denmark
Start Date
September 26, 2023
Primary Completion Date
March 1, 2027
Completion Date
March 1, 2027
Last Updated
March 20, 2025
NCT07325292
NCT05748015
NCT06433765
NCT07466823
NCT04876339
NCT05344469
Lead Sponsor
Odense University Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions